CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.960
  • 0.0000.00%
15min DelayTrading Apr 30 16:00 ET
50.90MMarket Cap-0.91P/E (TTM)

About Helix BioPharma Corp Company

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.

Company Profile

SymbolHBP
Company NameHelix BioPharma Corp
Founded1995
MarketTSE
Employees7
Fiscal Year Ends07-31
Address40 Temperance Street Suite 2700, Bay Adelaide Centre - North Tower
CityToronto
CountryCAN
Zip CodeM5H0B4
Phone+1 604 684-2181

Company Executives

  • Name
  • Position
  • Salary
  • Jacek Antas
  • Corporate Secretary, Chairman of the Board and Chief Executive Officer
  • --
  • James Murphy
  • Chief Financial Officer
  • --
  • Malgorzata Laube
  • Independent Director
  • --
  • Jerzy Leszczynski
  • Independent Director
  • --
  • Janusz Grabski
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More